Loading…

Effects of extracts from Corylopsis coreana Uyeki (Hamamelidaceae) flos on xanthine oxidase activity and hyperuricemia

Objectives This study aims to investigate xanthine oxidase (XO) inhibitory activity and antihyperuricemic effects of Corylopsis coreana Uyeki flos extracts and the phytochemicals contained therein. Methods Ethanolic extracts of the plant were prepared, and the extraction process was optimized with r...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmacy and pharmacology 2016-12, Vol.68 (12), p.1597-1603
Main Authors: Yoon, In-Soo, Park, Dae-Hun, Ki, Sung-Hwan, Cho, Seung-Sik
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives This study aims to investigate xanthine oxidase (XO) inhibitory activity and antihyperuricemic effects of Corylopsis coreana Uyeki flos extracts and the phytochemicals contained therein. Methods Ethanolic extracts of the plant were prepared, and the extraction process was optimized with respect to flavonoid content and XO inhibitory activity. The optimized ethanolic extract was tested for its XO inhibitory activity and antihyperuricemic effects in potassium oxonate‐induced hyperuricemic mice. Key findings The 80% ethanolic extract showed the highest total flavonoid content and in‐vitro XO inhibitory activity. In‐vivo studies demonstrated that the optimized 80% ethanolic extract could inhibit hepatic XO activity and significantly alleviate hyperuricemia at a relatively low oral dose (50 mg/kg) in mice. Additionally, an in‐vitro enzyme inhibition study showed that phytochemicals such as bergenin, isosalipurposide, quercetin and quercitrin may be the key constituents responsible for the observed antihyperuricemic effects of the extract. Conclusions This study is the first report on the XO inhibitory and antihyperuricemic effects of C. coreana Uyeki flos extract, which can be therapeutically applied in treating hyperuricemia and gout.
ISSN:0022-3573
2042-7158
DOI:10.1111/jphp.12626